E.O.S Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $366M

E.O.S General Information

Description

Developer of medicines for the treatment of cancer. The company also provides anti-proliferative agents and multikinase inhibitors.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • Via Monte di Pietà 1 / A
  • 20121 Milan(Lombardy)
  • Italy
+39 02
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Vertical(s)
Corporate Office
  • Via Monte di Pietà 1 / A
  • 20121 Milan(Lombardy)
  • Italy
+39 02

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

E.O.S Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 19-Nov-2013 $366M Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 01-Jul-2009 Completed Product Development
1. Seed Round 28-Jun-2007 $6.05M $6.05M Completed Startup
To view E.O.S’s complete valuation and funding history, request access »

E.O.S Patents

E.O.S Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3162274-A1 Time-temperature indicator Pending 12-Nov-2019
EP-4058764-A1 Time-temperature indicator Active 12-Nov-2019
EP-4058764-B1 Time-temperature indicator Active 12-Nov-2019
EP-4058764-C0 Time-temperature indicator Active 12-Nov-2019
US-12287245-B2 Time-temperature indicator Active 12-Nov-2019 G01K3/04
To view E.O.S’s complete patent history, request access »

E.O.S Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

E.O.S Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aescap Life Sciences Mutual Fund Minority
Sofinnova Partners Venture Capital Minority
Xyence Venture Capital Minority
To view E.O.S’s complete investors history, request access »

E.O.S FAQs

  • When was E.O.S founded?

    E.O.S was founded in 2006.

  • Where is E.O.S headquartered?

    E.O.S is headquartered in Milan, Italy.

  • What is the size of E.O.S?

    E.O.S has 11 total employees.

  • What industry is E.O.S in?

    E.O.S’s primary industry is Drug Discovery.

  • Is E.O.S a private or public company?

    E.O.S is a Private company.

  • What is the current valuation of E.O.S?

    The current valuation of E.O.S is .

  • What is E.O.S’s current revenue?

    The current revenue for E.O.S is .

  • How much funding has E.O.S raised over time?

    E.O.S has raised $23.1M.

  • Who are E.O.S’s investors?

    Aescap Life Sciences, Sofinnova Partners, and Xyence have invested in E.O.S.

  • When was E.O.S acquired?

    E.O.S was acquired on 19-Nov-2013.

  • Who acquired E.O.S?

    E.O.S was acquired by Clovis Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process